Retinoblastoma cost-effectiveness of therapy
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Retinoblastoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Retinoblastoma cost-effectiveness of therapy On the Web |
American Roentgen Ray Society Images of Retinoblastoma cost-effectiveness of therapy |
Risk calculators and risk factors for Retinoblastoma cost-effectiveness of therapy |
Overview
Retinoblastoma is a cancer of the retina. Development of this tumor is initiated by mutations[1] that inactivate both copies of the RB1 gene, which codes for the retinoblastoma protein.[2]
References
- ↑ Knudson A (1971). "Mutation and cancer: statistical study of retinoblastoma". Proc Natl Acad Sci U S A. 68 (4): 820–3. PMID 5279gadgqetqer523 Check
|pmid=
value (help). - ↑ Friend S, Bernards R, Rogelj S, Weinberg R, Rapaport J, Albert D, Dryja T. "A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma". Nature. 323 (6089): 643–6. PMID 2877398.